Invesco
MPLT

Invesco’s MapLight Therapeutics MPLT Stock Holding History

Invesco’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Sell
5,729
-6,523
-53% -$188K ﹤0.01% 3587
2026
Q1 		$249K Sell
12,252
-718
-6% -$12.8K ﹤0.01% 3409
2025
Q4 		$228K Buy
+12,970
New +$217K ﹤0.01% 3479

Other funds holding MPLT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco's MPLT Position: Q2 2026 in Review

Invesco reduced its MapLight Therapeutics (MPLT) stake by 53% in Q2 2026, selling an estimated $188K and leaving 5,729 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #3587.

Invesco first reported a position in MPLT in Q4 2025 and has held it in 3 quarters since. The position peaked at $249K in Q1 2026. 100 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

  • Invesco held 5,729 shares of MapLight Therapeutics worth $205K as of Q2 2026.
  • Invesco sold 6,523 MapLight Therapeutics shares in Q2 2026, an estimated $188K.
  • MapLight Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3587 holding.
  • Invesco first reported a position in MapLight Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Invesco's MapLight Therapeutics position peaked at $249K in Q1 2026.
  • 100 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.